middle.news
CurveBeam AI Advances China Strategy Despite FY2026 Revenue Decline
8:57am on Monday 31st of August, 2026 AEST
•
Healthcare
Read Story
CurveBeam AI Advances China Strategy Despite FY2026 Revenue Decline
8:57am on Monday 31st of August, 2026 AEST
Key Points
28% revenue decline to $8.67 million
12% increase in net loss to $18.83 million
Progress on China partnership with WEGO Orthopaedics
HiRiseTM achieves robotic surgery milestones
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Curvebeam AI (ASX:CVB)
OPEN ARTICLE